This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Andrew P. Lazar, MD, MPH; Paul Lazar, MD
Department of Dermatology Northwestern University Medical School 303 E Chicago Ave Chicago, IL 60611

Arch Dermatol. 1991;127(2):263.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

To the Editor.—

The cause-and-effect relationship between the exposure to silicone gel prostheses used in augmentation mammoplasty and sclerodermatous changes is still somewhat tenuous. A recent case report¹ about the association prompted this article concerning a patient who developed localized morphea 2 months after the implantation of a silicone gel-filled prosthesis.

Report of a Case.—

A 64-year-old white woman was seen in July 1988, 7 months after undergoing augmentation mammoplasty of the left breast. Other than having had breast cancer, she was generally in good health, taking only captopril (Capoten) for hypertension. She had never taken levotryptophan.

Seven weeks after the surgery she noticed a "bruise the size of a quarter." It changed to a reddish firm area with a slightly red rim and a pale center. Our clinical impression was morphea (localized scleroderma) confirmed by microscopic examination. Prior to the surgical implantation, the patient experienced mild arthritic symptoms . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?